Upon assessment of tumor-reactive CD8+ T cells, we found that the Batf−/− group had a significantly lower frequency of effector CX3CR1+ CD8+ T cells with a concomitant increase in Ly108− CX3CR1− exhausted CD8+ T cells (Figure 2C). This evidence concerns the gene CD8A and neoplasm.